This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Heptares Therapeutics Limited, Nxera Pharma UK Limited. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2026
Title: Christine Mary Richardson: Innovator in Cancer Treatment
Introduction
Christine Mary Richardson is a prominent inventor based in Saffron Walden, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer and other disorders. With a total of 6 patents to her name, Richardson's work is characterized by innovative approaches to drug design and therapeutic applications.
Latest Patents
Among her latest patents, Richardson has developed 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer. These triazalone compounds, described in her patent, include pharmaceutically acceptable salts and methods for their preparation and use. They are particularly useful as adenosine receptor antagonists, which can be beneficial in treating diseases mediated by the adenosine receptor, such as cancer, movement disorders, or attention disorders. Additionally, she has worked on 1,2,4-triazine-4-amine derivatives, which may be useful in treating conditions ameliorated by the inhibition of the A-Aor, especially the Areceptor.
Career Highlights
Richardson has held positions at notable companies, including Heptares Therapeutics Limited and Nxera Pharma UK Limited. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.
Collaborations
Throughout her career, Richardson has collaborated with esteemed colleagues such as Jonathan Stephen Mason and Miles Stuart Congreve. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Christine Mary Richardson's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her innovative spirit and dedication to improving healthcare. Her patents and collaborations reflect her commitment to advancing medical science and providing new solutions for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile